Medical Treatment for AS. Disclosures. Valvular Heart Disease. Aortic Stenosis. Severe Symptomatic AS Survival. Disease Progression in Aortic Stenosis
|
|
- Marshall Knight
- 5 years ago
- Views:
Transcription
1 Disclosures Valvular Heart Disease Akshay Desai, MD Brigham and Women s Hospital Harvard Medical School Consultant: Novartis Pharmaceuticals Boston Scientific Intel, Inc. Relypsa, Inc. Research Grants: AtCor Medical, Inc. Aortic Stenosis Disease Progression in Aortic Stenosis Otto C. N Engl J Med 8;359: Medical Treatment for AS Severe Symptomatic AS Survival Schwarz F et al. Circulation 1982;66:115 1
2 Severe Aortic Stenosis Surgical Treatment Indication ACC/AHA 1 ESC Symptoms I(B) I(B) Need for CABG/Ao Surgery I(C) I(C) LVEF <.5 I(C) I(C) Abnormal ETT IIb(C) IIa or b(c) Rapid Progression/Delay IIb(C) IIa(C) AVA <.6cm 2 IIb(C) Severe LVH (>15mm) IIb(C)* Case Study 84 year old man Active and asymptomatic Grade 3 late-peaking murmur ECG: LVH ECHO: Vmax 4.2 m/s, AVA.8 cm 2, EF.6 1. Bonow R et al. J Am Coll Cardiol 6;48; Vahanian A et al. European Heart Journal 7; 28: year old man Asymptomatic Case Study ECHO: Vmax 4.2 m/s, AVA.8 cm 2, EF.6 Watchful waiting Exercise testing TAVI? AVR Indications for Surgery Asymptomatic Severe AS Class IIb Abnormal response to exercise High likelihood of rapid progression Delay from symptom onset to surgery Extremely severe AS (AVA <.6 cm 2, V max > 5. m/s) with low (< 1%) operative mortality risk ACC/AHA Valve Guidelines 6 Transcatheter Aortic-Valve Replacement All Cause Mortality All-cause mortality (%) 6 4 Standard Rx TAVI HR [95% CI] =.54 [.38,.78] P (log rank) <.1 Months Smith CR et al. N Engl J Med 11;364: Numbers at Risk TAVI Standard Rx
3 Time-to-Event Curves for the Primary End Point and Other Selected End Points. PARTNER A 3 day 1 year TAVR AVR p TAVR AVR p Stroke/TIA All TIA Minor Major Major bleed < <.1 Smith CR et al. N Engl J Med 11;364: Data in % Smith C et al. ACC 11 Aortic Regurgitation Etiology VALVE BAV DISEASE RHEUMATIC IE MYXOMATOUS APLA FEN-PHEN? TRAUMA ROOT CT DISORDER DISSECTION IE AORTITIS HTN OTHER (Congenital) Acute Severe AR Urgent AVR 42 y/o woman MSSA AoV IE Normal valve Survival (percent) 6 4 Aortic Regurgitation Survival of Patients Treated Medically FC III-IV IV FC II FC I Survival (percent) 6 4 Aortic Regurgitation Survival After Aortic Valve Replacement p<.2 LVEF > 5% LVEF < 5% Time (years) from Dujardin et al. Circulation 1999;99: Time (years) Forman et al, Am J Cardiol 19;45:
4 Class I Symptoms Severe Aortic Regurgitation Indications for AVR Mild-moderate LV dysfunction (EF.25-.5) Need for other cardiac or aortic surgery Class II LVIDd > 75 mm; LVIDs > 55 mm or > 25mm/m 2 (IIa) LVIDd > 7 mm; LVIDs > 5mm; progressive (IIb) ACC/AHA Valve Guidelines 6 Asymptomatic with Normal LV Function (percent) Aortic Regurgitation Asymptomatic Patients with Normal LV Function 58% 6 n Annual Risk 3.8% 6.2% 4 Endpoints: 45% Symptoms Asymp LVD % of endpoints occur Death 2 4 before onset of symptoms Time (years) Bonow et al. Circulation 1991; 84: Borer et al. Circulation 1998; 97: Aortic Regurgitation Vasodilator Therapy BAV Disease Aortic Valve Replacement (%) 6 4 P=.29 Enalapril Nifedipine Control Years Mean SBP Evangelista A et al. NEJM 5; 353: Fazel SS et al. J Thorac Cardiovasc Surg 8; 135: Cardiac MRI BAV Disease BICUSPID AORTIC VALVE DISEASE CYSTIC MEDIAL DEGENERATION NORMAL VSMC APOPTOSIS? ROLE OF MMP-2 MARFAN BAV Nataatmadja M et al. Circulation 3; 18:II-329.
5 Bicuspid Aortic Valve Dilated Aortic Root Post-Natal Treatment with Propranolol vs Losartan Class I Indications for Surgery Maximal dimension > 5. cm or annual increase in size >.5 cm / year.* Maximal dimension > 4.5 cm and surgery indicated for severe AS or AR.* * Consider lower threshold values for patients of small stature of either gender ACC/AHA Valve Guidelines 6 Habashi J et al. Science 6; 312: Question 1 A 66 year old woman presents with mild dyspnea on exertion. HR 72 reg, BP 156/. Grade 3 late peaking murmur of aortic stenosis. ECG: NSR. LVH TTE: Calcified aortic valve, mean gradient 5 mm Hg, AVA=.8cm2. Wall thickness 1.5 cm. LVEF.75. Question 1 Which of the following treatments would you recommend? a. Diuretic and ACE-inhibitor with close follow-up b. Bioprosthetic aortic valve replacement c. Mechanical aortic valve replacement d. Percutaneous aortic balloon valvuloplasty Mitral Valve The Five Levels Mitral Regurgitation Etiology Leaflets Annulus LA endocardium Chordae tendineae Papillary muscles, LV Otto, CM. NEJM 1; 345:74 ACUTE MR Acute MI (Inf-Post) Endocarditis Trauma Acute on chronic CHRONIC MR Myxomatous Ischemic DCM Rheumatic MAC HOCM Other (APLS, etc.)
6 Rheumatic MR Incidence (%) Incidence of Post-operative LV Dysfunction Stratified by Pre-operative LVESD Medical Therapy Chronic MR ABx prophylaxis when and if indicated No role for vasodilator therapy in asymptomatic, Management of AF normotensive patients with Management chronic of severe CAD MR and normal LV function ACE-I or ARB for HTN, reduced EF < 3 < 35 < 4 < 45 >/= 45 LVESD (mm) Matsumura T et al. J Am Coll Cardiol 3; 42: 458 Chronic Severe MR NYHA FC I Asymptomatic Severe MR Survival with Conservative Management Clinical Eval 6 mo Echo 12 mo EF >.6 ESD < 4 mm No AF? PHT? MV Repair Highly Likely? Yes Class IIa Yes Class IIa MV Repair* MVR MV Repair* EF <.6 ESD > 4 mm Class I No ACC/AHA Valve Guidelines 6 Survival (%) All Patients Flail Leaflet Expected Survival Years Rosenhek R et al. Circulation 6; 113:
7 Ischemic MR Ischemic MR Badiwala, M. V. et al. Circulation 9;1: Mitral Regurgitation in DCM Question 2 A previously asymptomatic 5 yr old woman with mitral valve prolapse and mild mitral regurgitation presents with NYHA Function Class II dyspnea of 6 months duration. She had dental work done 2 weeks before symptom onset without antibiotic prophylaxis. HR 84 reg, BP 12/76. T Grade 3 systolic murmur at the apex. Question 2 Echocardiography now shows moderate-severe MR with a partially flail posterior leaflet. LVEF is 65%. 6 blood cultures are negative. Question 2 Which of the following strategies would you pursue? Careful clinical follow-up with echo studies at 3-month intervals ACE inhibitor therapy Mitral valve replacement Mitral valve repair
8 MITRAL STENOSIS MITRAL STENOSIS ANTICOAGULATION AF: Paroxysmal, Persistent, Permanent Hx TIA/CVA, Systemic embolus Presence of LA thrombus LA > 5.5cm or Spontaneous Contrast PMBV CLASS 1 INDICATIONS Symptoms PA HTN (PA > 5 rest, > 6 ex) Predicated on: 1. Favorable morphology 2. Operator and Lab experience Absent: 1. Moderate to severe MR 2. LA thrombus 3. Inability to perform trans-septal puncture Infective Endocarditis Prophylaxis AHA Guidelines 7 Prophylaxis for dental procedures is recommended only for patients with the highest risk of adverse outcomes from IE. Prosthetic valve Previous IE Congenital heart disease* Cardiac transplant survivor with VHD Question 3 A 71 year old woman with a St. Jude MVR and AF is scheduled for laparoscopic cholecystectomy. She had a TIA 2 years ago. She takes warfarin, low dose aspirin, metoprolol succinate, and furosemide. Labs include INR 3.4, BUN 42, Scr 2.1. Prophylaxis is not recommended for GI or GU procedures. Circulation 7. Published online 4/19/7.
9 Question 3 Which of the following strategies for anticoagulation management would you advise? a. Taper warfarin and operate when INR 2. b. Hold warfarin for 5 days and operate c. Hold warfarin, admit for IV UFH when INR < 2.5 d. Hold warfarin, bridge with enoxaparin, 1 mg/kg bid SYNDROMES ASSOCIATED WITH CONGENITAL HEART DISEASE DOWN S: AV Canal, VSD, Primum ASD TURNER S: Coarctation, AS NOONAN S: PS WILLIAM S: SVAS, PS HOLT-ORAM: Secundum ASD MARFAN: Aortic aneurysm, MVP ATRIAL SEPTAL DEFECT ATRIAL SEPTAL DEFECT Types: secundum, primum, sinus venosus, coronary sinus Exam: Grade 2 MSM, fixed splitting S2 ECG: IRBB. LAD = primum. ECHO: RV volume overload, shunt flow, associated findings (MVP, cleft MV, APVD) SECUNDUM ASD PATENT FORAMEN OVALE Present in 25-3% of population Sometimes associated with interatrial septal aneurysm Implied role in Cryptogenic stroke Migraine Platypnea-orthodeoxia Decompression sickness
10 TETRALOGY OF FALLOT TETRALOGY OF FALLOT VSD (NON-RESTRICTIVE, LARGE) OVERRIDING AORTA RVOT OBSTRUCTION RVH COARCTATION AORTIC COARCTATION BAV DISEASE PRESENTATION: HTN, claudication ASSOCIATIONS: BAV, dissection, intracranial aneurysms, Turner s Syndrome (XO) EXAM: Murmur(s), BP Arm > Leg; pulse delay CXR: 3 Sign, Rib notching TREATMENT: Stenting, surgery OUTCOMES Lembeke A et al.circulation 3;17:e
2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease
2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease Patrick T. O Gara, MD BWH Heart and Vascular Center Professor of Medicine, Harvard Medical School Disclosures NHLBI CTSN Co-chair
More informationPrimary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017
Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board
More informationValvular Heart Disease
Valvular Heart Disease B K Singh, MD, FACC Disclosures: None 1 CARDIAC CYCLE S2 S2=A2P2 S1=M1T1 S4 S1 S3 2 JVP Carotid S1 Slitting of S2 S3 S4 Ejection click Opening snap Dynamic Auscultation What is the
More informationValvular Heart Disease. Dr. HANAN ALBACKR
Valvular Heart Disease Dr. HANAN ALBACKR Valvular Heart Disease Format for this lecture IMPORTANT CLINICAL INFO know for boards, tests and clinical practice Spectrum of VHD Aortic Valve Mitral Valve Tricuspid
More informationMITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center
MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT Irene Frantzis P year, SGUL Sheba Medical Center MITRAL VALVE DISEASE Mitral Valve Regurgitation Mitral Valve Stenosis Mitral Valve Prolapse MITRAL REGURGITATION
More informationValvular Heart Disease: Assessment and Timing of Intervention. Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust
Valvular Heart Disease: Assessment and Timing of Intervention Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust Disclosures: Speaker fee: Bayer Acknowledgements: Matt Shun-Shin
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationUptofate Study Summary
CONGENITAL HEART DISEASE Uptofate Study Summary Acyanotic Atrial septal defect Ventricular septal defect Patent foramen ovale Patent ductus arteriosus Aortic coartation Pulmonary stenosis Cyanotic Tetralogy
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationAsymptomatic Valvular Disease:
Asymptomatic Valvular Disease: Can Echocardiography Help You Decide When to Intervene? Neil J. Weissman, MD MedStar Health Research Inst at MedStar Washington Hospital Center & Professor of Medicine Georgetown
More informationValvular Guidelines: The Past, the Present, the Future
Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,
More informationTAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central
TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central Michigan University 1 Disclosure Chiesi Pharma- Consultant
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationCritical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials
Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Pregnancy and Congenital Heart Disease Case Review Heidi M. Connolly, M.D. Professor of Medicine Chair for Education
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationValvular Heart Disease: Recognition and Management in the Outpatient Setting
Valvular Heart Disease: Recognition and Management in the Outpatient Setting Ian S. Harris UCSF Division of Cardiology Case 1: 80 year old man with a history of hypertension, complaining of exertional
More informationCongenital heart disease. By Dr Saima Ali Professor of pediatrics
Congenital heart disease By Dr Saima Ali Professor of pediatrics What is the most striking clinical finding in this child? Learning objectives By the end of this lecture, final year student should be able
More informationReshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid
Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid Patient records 76 y.o. male Hypertension. Dyslipidemia. OPLD. Smoked in the past. Diabetes
More informationLow Gradient Severe? AS
Low Gradient Severe? AS Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Institut Universitaire de Cardiologie et de Pneumologie de Québec / Québec Heart
More informationStress Testing in Valvular Disease
2017 ASE Florida Orlando, FL October 10, 2017 2:40 2:50 PM 10 min Grand Harbor Ballroom South Stress Testing in Valvular Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate
More informationClinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'
More informationNotes by Sandra Dankwa 2009 HF- Heart Failure DS- Down Syndrome IE- Infective Endocarditis ET- Exercise Tolerance. Small VSD Symptoms -asymptomatic
Congenital Heart Disease: Notes. Condition Pathology PC Ix Rx Ventricular septal defect (VSD) L R shuntsdefect anywhere in the ventricle, usually perimembranous (next to the tricuspid valve) 30% 1)small
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationHow does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE
How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? Prof. Patrizio LANCELLOTTI, MD, PhD GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège, CHU
More informationMiscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease. Pregnancy and Cardiovascular Disease MCQ
Miscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease Maan Jokhadar, MD, FACC Emory Center for Advanced Heart Failure Therapy Emory Adult Congenital Heart Center Pregnancy
More informationValve Disease in the Pregnant Patient
Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If
More informationLoad and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic
Load and Function - Valvular Heart Disease Tom Marwick, Cardiovascular Imaging Cleveland Clinic Indications for surgery in common valve lesions Risks Operative mortality Failed repair - to MVR Operative
More informationValvular Intervention
Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone
More informationHeart Valve disease: MR. AS tough patient When to echo, When to refer, What s new
Heart Valve disease: MR. AS tough patient When to echo, When to refer, What s new B. Sonnenberg UAH Cardiology CME Day 5 May 2015 Disclosures Speaker s or Advisory Boards: none Research grants: none (co-investigator
More informationECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT
ECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT Karen Stout, MD, FACC Divisions of Cardiology University of Washington Medical Center Seattle Children s Hospital NO DISCLOSURES
More informationMitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France
Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related
More informationSpotlight on Valvular Heart Disease Guidelines
Spotlight on Valvular Heart Disease Guidelines Aortic Valve Disease Raphael Rosenhek Department of Cardiology Medical University of Vienna Palermo, April 26 th 2018 1998 2002 2006 2007 2008 2012 2014 2017
More informationNON SURGICAL TREATMENT OF CARDIAC DISEASE PETER J SABIA, MD FACC ASSOCIATES IN CARDIOLOGY SILVER SPRING, MARYLAND
NON SURGICAL TREATMENT OF CARDIAC DISEASE PETER J SABIA, MD FACC ASSOCIATES IN CARDIOLOGY SILVER SPRING, MARYLAND TOPICS ATRIAL SEPTAL DEFECT VSD IHSS PERCUTANEOUS AORTIC VALVE PERCUTANEOUS MITRAL VALVE
More informationAortic stenosis and regurgitation
1 Aortic stenosis and regurgitation valvuloplasty and replacement Mitral regurgitation and stenosis valvuloplasty and repair/replacement 2 ASD PFO VSD PDA occlusion Left atrial appendage occlusion for
More informationAortic regurgitation and aneurysm. epidemiology and guidelines
Reconstruction of the Aortic Valve and Root A practical approach Aortic regurgitation and aneurysm epidemiology and guidelines Sebastian Ewen Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische
More informationAcute Valve Regurgitation Catherine M. Otto, MD J. Ward Kennedy-Hamilton Endowed Chair in Cardiology University of Washington, Seattle
Acute Valve Regurgitation Catherine M. Otto, MD J. Ward Kennedy-Hamilton Endowed Chair in Cardiology University of Washington, Seattle No conflicts of interest Acute Aortic Regurgitation Causes aortic
More informationESC / EACTS new valvular guidelines- Update
ESC / EACTS new valvular guidelines- Update Yaron Shapira, MD The Dan Sheingarten echocardiography & valve clinic Rabin Medical Center, Beilinson Hospital, Petah-Tiqva Tel-Aviv University ESC valve guidelines
More informationAdult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016
1 Adult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Why should all echocardiographers
More informationValvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD
Valvular Heart Disease Transcatheter Valve Therapies October 2016 Brian Whisenant MD Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
More informationAortic Valvular Stenosis
Aortic Valvular Stenosis How to Assess the Four Variables for Management Low Flow / Low Gradient / Normal EF / Low EF Patrick T. O Gara, MD, MACC Brigham and Women s Hospital Harvard Medical School No
More informationValvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong
Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong Management of valvular heart disease Accurate diagnosis and disease severity Prevention and treatment
More informationHow does taking warfarin affect Exercise Regimen? By Dr.*~LoOKTaO ~* ÿ
How does taking warfarin affect Exercise Regimen? By Dr.*~LoOKTaO ~* ÿ no consistent recommendations available regarding safety of certain sports & exercise any sports w/ high risk of trauma, especially
More informationChronic Primary Mitral Regurgitation
Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......
More informationLearn and LiveSM. ACC/AHA Pocket Guideline. Based on the ACC/AHA 2006 Guideline Revision. Management of Patients With. Valvular Heart Disease
Learn and LiveSM ACC/AHA Pocket Guideline Based on the ACC/AHA 2006 Guideline Revision Management of Patients With Valvular Heart Disease June 2006 Special thanks to Distributed through support from Medtronic
More informationValvular Heart Disease Mitral Stenosis
Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema
More informationThe Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives. Martin B. Leon, MD
The Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New
More informationAdult Congenital Heart Disease
Adult Congenital Heart Disease Anne Marie Valente, MD Boston Adult Congenital Heart Disease and Pulmonary Hypertension Program Division of Cardiology Brigham and Women s Hospital, Boston Children s Hospital
More informationSONOGRAPHER & NURSE LED VALVE CLINICS
SONOGRAPHER & NURSE LED VALVE CLINICS Frequency of visits and alerts AORTIC STENOSIS V max > 4.0 m/s or EOA < 1.0 cm 2 V max 3.5 4.0 m/s + Ca+ V max 3.0 4.0 m/s or EOA 1.0-1.5 cm 2 V max 2.5 3.0 m/s every
More informationSevere Asymptomatic Aortic Stenosis
Severe Asymptomatic Aortic Stenosis The Clinician s Perspective Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital
More informationEcho in Asymptomatic Mitral and Aortic Regurgitation
2017 ASE Florida Orlando, FL October 9, 2017 10:40 11:00 PM 20 min Grand Harbor Ballroom South Echo in Asymptomatic Mitral and Aortic Regurgitation Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology
More informationPregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia
Pregnancy, Heart Disease and Imaging Sangeeta Shah, MD, FASE, FACC Associate Professor, Ochsner Clinical School of Medicine Advanced CV Imaging and Adult Congenital Heart Disease New Orleans, LA Hemodynamics
More informationAortic Stenosis.
Aortic Stenosis www.cardiconcept.com Common causes Normal Rheumatic (Rim or Commissures) Calcific Degenerative Bicuspid Adapted from C. Otto, Principles of Echocardiography, 2007 Rare causes Congenital
More informationLong-Term Outcome of Patients With Aortic Regurgitation: Medical Management and Surgical Indications
24th Annual Advances in Heart Disease 16 December 2007 Long-Term Outcome of Patients With Aortic Regurgitation: Medical Management and Surgical Indications Melvin D. Cheitlin, M.D. Emeritus Professor of
More informationPercutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat
Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,
More information8/31/2016. Mitraclip in Matthew Johnson, MD
Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure
More informationWatchman and Structural update..the next frontier. Ari Chanda, MD Cardiology Associates of Fredericksburg
Watchman and Structural update..the next frontier Ari Chanda, MD Cardiology Associates of Fredericksburg Different Left Atrial Appendage (LAA) morphologies Watchman (the device) Fabric Anchors Device structure
More informationManagement of Patients With Valvular Heart Disease. ACC/AHA Pocket Guidelines
ACC/AHA Pocket Guidelines Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines July 2000 ACC/AHA
More information2018 ACOI-Internal Medicine Board Review Valvular and Congenital Heart Disease. Robert Bender, DO, FACOI, FACC
2018 ACOI-Internal Medicine Board Review Valvular and Congenital Heart Disease Robert Bender, DO, FACOI, FACC Endocarditis Prophylaxis AHA (2007) = antibiotic prophylaxis recommended only for patients
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationA new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center
A new option for the Diagnosis and Management of Valvular Heart Disease Oregon Comprehensive Valve Center I have no disclosures Oregon Comprehensive Valve Center Weekly multidisciplinary case conferences
More informationAortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -
Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo
More informationManagement of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France
Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France Background Aortic stenosis (AS) is the most frequent valve disease among referred
More informationEchocardiography in Adult Congenital Heart Disease
Echocardiography in Adult Congenital Heart Disease Michael Vogel Kinderherz-Praxis München CHD missed in childhood Subsequent lesions after repaired CHD Follow-up of cyanotic heart disease CHD missed in
More informationMitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna
Mitral Valve Disease Prof. Sirchak Yelizaveta Stepanovna Fall 2008 Mitral Valve Stenosis Lecture Outline Mitral Stenosis Mitral Regurgitation Etiology Pathophysiology Clinical features Diagnostic testing
More informationAortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?
Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV? Samin K Sharma, MD, FACC, FSCAI Director Clinical & Interventional
More informationCandice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada
PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary
More informationCardiovascular Recommendation Tables
Cardiovascular Recommendation Tables Current as of: February, 2009 The first publication of the Cardiovascular Recommendation Tables occurred in the October 2002, Cardiovascular Advisory Panel Guidelines
More informationTranscatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data
Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,
More informationInterventions in Adult Congenital Heart Disease: Role of CV Imaging. Associate Professor. ACHD mortality. Pillutla. Am Heart J 2009;158:874-9
Interventions in Adult Congenital Heart Disease: Role of CV Imaging Sangeeta Shah MD, FACC, FASE Associate Professor ACHD mortality Pillutla. Am Heart J 2009;158:874-9 Adult Congenital Heart Disease Heterogenity
More informationPERCUTANEOUS TRANSLUMINAL MITRAL VALVULOPLASTY IN POST MITRAL VALVE REPAIR AND AORTIC VALVE REPLACEMENT PATIENT
PERCUTANEOUS TRANSLUMINAL MITRAL VALVULOPLASTY IN POST MITRAL VALVE REPAIR AND AORTIC VALVE REPLACEMENT PATIENT Chandra Mani Adhikari, 1 Rabi Malla, 1 Raamesh Koirala, 2 Dipanker Prajapati, 1 Navin Gautam
More informationUnderstanding the guidelines for Interventions in MR. Ali AlMasood
Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe
More informationECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction
Role of Stress Echo in Valvular Heart Disease ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan Not only ischemia! Cardiomyopathy Prosthetic Valve Diastolic
More informationAdult Cardiac Surgery
Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease
More informationS. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences
S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences No financial disclosures Aorta Congenital aortic stenosis/insufficiency
More informationWorldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates
Michael Sumners DO Epidemiology Worldwide rheumatic fever is the most common cause of valve disease In industrialized areas, valvular disease of old age predominates Calcific aortic stenosis Functional
More informationΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ
ΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ European Accreditation in TTE, TEE and CHD Echocardiography NOTHING TO DECLARE ATRIAL SEPTAL DEFECT TYPES SECUNDUM
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationMaternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE
Maternal Cardiac Disease In Pregnancy August 25, 2017 PREGNANCY ECHO CONFERENCE Maternal Physiology Cardiac Output = HR x SV Non-pregnant: 4.5 L/min Pregnant: 6.0 L/min Increase most acute in first 10
More informationCongenital Heart Disease An Approach for Simple and Complex Anomalies
Congenital Heart Disease An Approach for Simple and Complex Anomalies Michael D. Pettersen, MD Director, Echocardiography Rocky Mountain Hospital for Children Denver, CO None Disclosures 1 ASCeXAM Contains
More informationM-Mode Echocardiography Is it still Alive? Itzhak Kronzon, MD,FASE. Sampling Rate M-Mode: 1800 / sec 2D: 30 / sec
M-Mode Echocardiography Is it still Alive? Itzhak Kronzon, MD,FASE Honoraria: Philips Classical M-mode Echocardiography M-Mode offers better time and image resolution. Sampling Rate M-Mode: 1800 / sec
More informationPrimary Mitral Regurgitation
EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,
More informationPATENT DUCTUS ARTERIOSUS (PDA)
PATENT DUCTUS ARTERIOSUS (PDA) It is a channel that connect the pulmonary artery with the descending aorta (isthumus part). It results from the persistence of patency of the fetal ductus arteriosus after
More informationTREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC
TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS
More informationRole of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan
Role of Stress Echo in Valvular Heart Disease Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Exercise echocardiography Dobutamine echocardiography Usefulness of exercise echo
More informationEchocardiographic assessment in Adult Patients with Congenital Heart Diseases
Echocardiographic assessment in Adult Patients with Congenital Heart Diseases Athanasios Koutsakis Cardiologist, Cl. Research Fellow George Giannakoulas Ass. Professor in Cardiology 1st Cardiology Department,
More informationOrganic mitral regurgitation
The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality
More informationAdult Congenital Heart Disease for the Internist
Adult Congenital Heart Disease for the Internist Saurabh Rajpal, MBBS, MD Assistant Professor Department of Internal Medicine Division of Cardiovascular Medicine The Ohio State University Wexner Medical
More informationAdult Congenital Heart Disease for the Internist
Adult Congenital Heart Disease for the Internist Saurabh Rajpal, MBBS, MD Assistant Professor Department of Internal Medicine Division of Cardiovascular Medicine The Ohio State University Wexner Medical
More informationSevere left ventricular dysfunction and valvular heart disease: should we operate?
Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict
More information2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR
TRANSCATHETER AORTIC VALVE REPLACEMENT IN 2018: IS IT NOW THE STANDARD OF CARE? 22 ND ANNUAL COASTAL CARDIAC & VASCULAR CONFERENCE FEBRUARY 17, 2018 R. David Anderson, MD, MS, FACC, FSCAI Professor of
More informationAssessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University
Assessment and Preparation of Patients with TAVI Rob Tanzola Associate Professor, Queen s University My patient has aortic stenosis and needs non-cardiac surgery Should (s)he get a TAVI? Rob Tanzola Associate
More informationDECLARATION OF CONFLICT OF INTEREST. No disclosures
DECLARATION OF CONFLICT OF INTEREST No disclosures Congenital Aortic Valve Disease and Aortopathy: Recent Advances Sub- and Supravalvular Aortic Stenosis Westfälische Wilhelms-Universität Münster Helmut
More informationBlank DISCLOSURES 1/17/2017 COMPLEX VALVE CASES CHALLENGES IN EVALUATING AND MANAGING MULTIVALVULAR HEART DISEASE ECHO HAWAII 1/23/17 NONE
Blank COMPLEX VALVE CASES ECHO HAWAII 1/23/17 1 David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine Director, Structural Heart Imaging The Ohio State University Division of Cardiovascular Medicine
More informationAortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC
Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC No Financial Disclosures Aortic Stenosis AS is an insidious disease with a long latency period followed by
More informationUptofate Study Summary
CARDIOLOGY: Valvulopathies Aortic Stenosis 1. Aetiology is age dependant - Age > 70: Senile calcification (50%), rheumatic (25%), biscupid (25%) - Age < 70: Bicuspid (75%), rheumatic (25%) - Note: Rheumatic
More informationAortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants
Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants Martin G. Keane, MD, FASE Professor of Medicine Lewis Katz School of Medicine at Temple University Basic root structure Parasternal
More informationWelcome 17 Michigan TAVR Participating Hospitals!
Welcome 17 Michigan TAVR Participating Hospitals! 1 MICHIGAN TAVR BRIEF OVERVIEW HOW AND WHY PRE-TAVR IMAGING EVALUATION AND THE TVT Michael Grossman, MD Co-Director, BMC2 Coordinating Center Why Michigan
More information